Barbara Chie-Leon
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Resistance in Bacteria 3
-
- Protein Degradation and Inhibitors 4
- RNA and protein synthesis mechanisms 4
- Ubiquitin and proteasome pathways 4
- Phosphodiesterase function and regulation 2
- Co-authors
- Antonia Lopez‐Girona (1 shared paper)Yan Ren (1 shared paper)Hideki Ando (1 shared paper)Toshio Hakoshima (1 shared paper)Philip P. Chamberlain (1 shared paper)Thomas O. Daniel (1 shared paper)Hiroshi Handa (1 shared paper)Maria Wang (1 shared paper)
- Journals
- SLAS DISCOVERY (2 papers)ACS Chemical Biology (1 paper)Journal of the American Chemical Society (1 paper)Journal of Molecular Biology (1 paper)Cell chemical biology (1 paper)
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Barbara Chie-Leon
12 papers receiving 729 citations
Barbara Chie-Leon's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 217
- Molecular Medicine 54
- Molecular Biology 629
- Oncology 172
- Genetics 29
Countries citing papers authored by Barbara Chie-Leon
This map shows the geographic impact of Barbara Chie-Leon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Chie-Leon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Chie-Leon more than expected).
Fields of papers citing papers by Barbara Chie-Leon
This network shows the impact of papers produced by Barbara Chie-Leon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Chie-Leon. The network helps show where Barbara Chie-Leon may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Chie-Leon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs Hit paper breakdown → | 2014 | 436 |
| 2 | 2023 | 116 | |
| 3 | 2004 | 40 | |
| 4 | 2024 | 35 | |
| 5 | 2020 | 34 | |
| 6 | 2012 | 21 | |
| 7 | 2019 | 19 | |
| 8 | 2012 | 19 | |
| 9 | 2012 | 17 | |
| 10 | 2013 | 17 | |
| 11 | 2011 | 13 | |
| 12 | 2023 | 4 |
About Barbara Chie-Leon
Barbara Chie-Leon is a scholar working on Molecular Medicine, Molecular Biology, Genetics, Hematology and Pharmacology, having authored 12 papers that have together received 771 indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (5 papers), Protein Degradation and Inhibitors (4 papers), RNA and protein synthesis mechanisms (4 papers), Ubiquitin and proteasome pathways (4 papers), Enzyme Structure and Function (3 papers), Antibiotic Resistance in Bacteria (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Phosphodiesterase function and regulation (2 papers). The work is most often cited by research in Hematology (217 citations), Molecular Medicine (54 citations), Molecular Biology (629 citations), Oncology (172 citations) and Genetics (29 citations). Barbara Chie-Leon has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Antonia Lopez‐Girona, Yan Ren, Hideki Ando, Toshio Hakoshima, Philip P. Chamberlain, Thomas O. Daniel, Hiroshi Handa, Maria Wang, Brian E. Cathers and Yoshinori Hirano. Their work appears in journals such as SLAS DISCOVERY, ACS Chemical Biology, Journal of the American Chemical Society, Journal of Molecular Biology and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.